ロード中...
Impact of the gut microbiome on immune checkpoint inhibitor efficacy—a systematic review
BACKGROUND: Immune checkpoint inhibitors (icis) are increasingly being used in clinical practice, improving outcomes for cancer patients. Preclinical models showed significant interaction between the gut microbiome (gm) and response to icis. However, that interaction remains unclear in clinical prac...
保存先:
| 出版年: | Curr Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Multimed Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927774/ https://ncbi.nlm.nih.gov/pubmed/31896938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.5177 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|